These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36737716)

  • 21. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vagus nerve stimulation for pediatric patients with intractable epilepsy between 3 and 6 years of age: study protocol for a double-blind, randomized control trial.
    Ji T; Yang Z; Liu Q; Liao J; Yin F; Chen Y; Zou L; Li B; Gao Y; Shu X; Huang S; Gao F; Liang J; Lin SF; Peng J; Song S; Wang J; Che C; Sun W; Tian M; Yang L; Hua Y; Hao Y; Cai L; Li L; Jiang Y
    Trials; 2019 Jan; 20(1):44. PubMed ID: 30642370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Randomized Sham-Controlled Cross-Over Study on the Short-Term Effect of Non-Invasive Cervical Vagus Nerve Stimulation on Spinal and Supraspinal Nociception in Healthy Subjects.
    Alt LK; Wach K; Liebler EJ; Straube A; Ruscheweyh R
    Headache; 2020 Sep; 60(8):1616-1631. PubMed ID: 32592516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inter-ictal assay of peripheral circulating inflammatory mediators in migraine patients under adjunctive cervical non-invasive vagus nerve stimulation (nVNS): A proof-of-concept study.
    Chaudhry SR; Lendvai IS; Muhammad S; Westhofen P; Kruppenbacher J; Scheef L; Boecker H; Scheele D; Hurlemann R; Kinfe TM
    Brain Stimul; 2019; 12(3):643-651. PubMed ID: 30745260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study.
    Silberstein SD; Calhoun AH; Lipton RB; Grosberg BM; Cady RK; Dorlas S; Simmons KA; Mullin C; Liebler EJ; Goadsby PJ; Saper JR;
    Neurology; 2016 Aug; 87(5):529-38. PubMed ID: 27412146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent exergaming and transcranial direct current stimulation to improve balance in people with Parkinson's disease: study protocol for a randomised controlled trial.
    Harris DM; Rantalainen T; Muthalib M; Johnson L; Duckham RL; Smith ST; Daly RM; Teo WP
    Trials; 2018 Jul; 19(1):387. PubMed ID: 30012175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variable- versus constant-frequency deep-brain stimulation in patients with advanced Parkinson's disease: study protocol for a randomized controlled trial.
    Jia F; Zhang J; Wang H; Liang Z; Liu W; Wang X; Liu Y; Guo Y; Ling Z; Cai X; Wu X; Wu J; Lv W; Xu X; Zhang W; Li L
    Trials; 2019 Dec; 20(1):749. PubMed ID: 31856908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ReSPonD trial--rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen.
    Henderson EJ; Lord SR; Close JC; Lawrence AD; Whone A; Ben-Shlomo Y
    BMC Neurol; 2013 Dec; 13():188. PubMed ID: 24299497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcutaneous electrical vagus nerve stimulation to suppress premature ventricular complexes (TREAT PVC): study protocol for a multi-center, double-blind, randomized controlled trial.
    Cai C; Wu N; Yang G; Yang S; Liu W; Chen M; Po SS;
    Trials; 2023 Oct; 24(1):683. PubMed ID: 37872628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential efficacy of non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A meta-analysis.
    de Coo IF; Marin JC; Silberstein SD; Friedman DI; Gaul C; McClure CK; Tyagi A; Liebler E; Tepper SJ; Ferrari MD; Goadsby PJ
    Cephalalgia; 2019 Jul; 39(8):967-977. PubMed ID: 31246132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the combination of automated peripheral mechanical stimulation and physical exercise on aerobic functional capacity and cardiac autonomic control in patients with Parkinson's disease: a randomized clinical trial protocol.
    Zelada-Astudillo N; Moreno VC; Herrera-Santelices A; Barbieri FA; Zamunér AR
    Trials; 2021 Apr; 22(1):250. PubMed ID: 33823928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial.
    Najib U; Smith T; Hindiyeh N; Saper J; Nye B; Ashina S; McClure CK; Marmura MJ; Chase S; Liebler E; Lipton RB
    Cephalalgia; 2022 Jun; 42(7):560-569. PubMed ID: 35001643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of augmenting cholinergic function on gait and balance.
    Mancini M; Fling BW; Gendreau A; Lapidus J; Horak FB; Chung K; Nutt JG
    BMC Neurol; 2015 Dec; 15():264. PubMed ID: 26697847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-invasive vagus nerve stimulation in a hungry state decreases heart rate variability.
    Altınkaya Z; Öztürk L; Büyükgüdük İ; Yanık H; Yılmaz DD; Yar B; Değirmenci E; Dal U; Veldhuizen MG
    Physiol Behav; 2023 Jan; 258():114016. PubMed ID: 36334796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcutaneous vagal nerve stimulation improves gastroenteric complaints in Parkinson's disease patients.
    Kaut O; Janocha L; Weismüller TJ; Wüllner U
    NeuroRehabilitation; 2019 Dec; 45(4):449-451. PubMed ID: 31868695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholinesterase inhibitor to prevent falls in Parkinson's disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson's disease.
    Neumann S; Taylor J; Bamford A; Metcalfe C; Gaunt DM; Whone A; Steeds D; Emmett SR; Hollingworth W; Ben-Shlomo Y; Henderson EJ
    BMC Neurol; 2021 Oct; 21(1):422. PubMed ID: 34715821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined STN/SNr-DBS for the treatment of refractory gait disturbances in Parkinson's disease: study protocol for a randomized controlled trial.
    Weiss D; Wächter T; Meisner C; Fritz M; Gharabaghi A; Plewnia C; Breit S; Krüger R
    Trials; 2011 Oct; 12():222. PubMed ID: 21989388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcutaneous vagus nerve stimulation in erosive hand osteoarthritis: protocol for the randomised, double-blind, sham-controlled ESTIVAL trial.
    Courties A; Deprouw C; Rousseau A; Berard L; Touati A; Kalsch J; Villevieille M; Maheu E; Miquel A; Simon T; Berenbaum F; Sellam J;
    BMJ Open; 2022 Mar; 12(3):e056169. PubMed ID: 35318234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.